The top 10
Selected from three inputs, not memory: the Men's Health Atlas 2026 rankings (updated Nov 10 to 12, 2026), FDD-based franchise footprint data (wellnessfranchisehq.com, Nov 7, 2026), and telehealth market presence (subscriber counts, rankings, ad visibility). One adjustment: Low T Center and SynergenX are the same company mid-rebrand, so they are merged and PeterMD was promoted to keep ten distinct companies. Open a card for the full offer history, ad evidence, sources, and what is still unverified. This top 10 is the shared national layer: the telehealth profiles apply in every regional view above; the in-person profiles (Ageless, SynergenX, Optimize U, 4Ever Young) apply only in the views where the regional panels verify them.
Showing all 10 competitors.
In-person chain · Corporate-ownedDirection: steady
Footprint: clinic count is genuinely murky. Its homepage says 65+, landing pages say 75+, third parties count 80+, and a June 2026 opening video says 94 clinics across 21 states. No single figure is confirmed. Why top 10: largest in-person men's health chain after Gameday; Atlas in-person TRT ranking #3. Founded 2007. Weekly in-clinic TRT injections, weight loss, skin care. Telehealth available except NJ and MS.
Current offer · Nov 2026
No published prices anywhere
The offer is “Make an Appointment,” plus free lab draws run as local pop-up events at gyms, chiropractors, and salons: Nov 2, 8, and 14, 2026. Insurance accepted (copay + deductible). A self-pay rate exists but the amount is unpublished.
Offer history, ad evidence, sources
Aug–Nov 2026
- No price or national offer shift: nothing published to move. The offer stayed appointment-led with free labs all window.
- Free-lab pop-ups every month: Aug 24 (Ankeny); Sep 4, 22, 24; Oct 22; Nov 2, 8, 14.
- Growth is by new clinics and pop-ups, not offer escalation. Schaumburg, IL and Cincinnati “coming soon”; Rancho Cucamonga hiring Oct 4, 2026.
Ad and social evidence
Runs Meta lead ads: an indexed landing URL shows campaign “OCT26 - Leads_TRT_InstagramVideo4” with geo ad sets (try.agelessmenshealth.com, UTM parameters read Nov 12, 2026).
Name trap, verified
Try Ageless (tryageless.com) and AgelessRx are separate companies. Both are excluded from this profile.
UNVERIFIED: any Ageless price at all. Exact clinic count (65 vs 75 vs 80+ vs 94). Any guarantee or refund terms. Meta Ad Library contents: direct read returned HTTP 403 on Nov 12, 2026.
Sources: agelessmenshealth.com and try.agelessmenshealth.com landing pages (checked Nov 12, 2026) · menshealthatlas.com/compare/best-in-person-trt-clinics/ (updated Nov 10, 2026) · dated Facebook event posts for free lab draws, Aug–Nov 2026.
Hybrid chain + telehealth · incl. Low T Center & HerKareDirection: more aggressive
Footprint: ~64 clinics across 10–11 states (company figure, July 2026), Texas-heavy; about 40–47 are Low T Center clinics. 500,000+ patients claimed. Bills insurance, HSA/FSA accepted. Chapter 11: filed Jul 2, 2026 (S.D. Texas, Case No. 26-90644, confirmed from Stretto court filings), operating as debtor-in-possession. By clinic count they are far smaller than Gameday (64 vs 430+), despite their self-claimed “largest hybrid provider” line.
Current offers · verified live Nov 12, 2026
Free T test + free consult, through Dec 31
Women's full hormone panel $99 (marked down from a $299 eval) through Dec 31. $250 referral credit, standing. Free B12 shot for new patients, Oct 1 to Nov 30. Self-inject treatment from $105/mo. Online TRT launched Nov 3 across Texas: $99 first month, then $199/mo.
Offer history, ad evidence, sources
Aug–Nov 2026
- Jul 3: “$250 for 250” initiative launched (BusinessWire). Jul 11: Tyler, TX grand opening with free T test and $99 women's eval.
- August: no dated company offer or announcement found. Gap stated, not filled.
- Sep 24–26: Southwest San Antonio relocation and grand opening with a $500 referral spike, 2x the standing $250.
- Oct 1: free B12 shot promo launched. Nov 3: online TRT launched across Texas, a direct move into the telehealth space they positioned against in September.
- Nov 14 (scheduled): Greenwood / Indianapolis grand opening repeats the playbook: free T test, $99 women's panel, $500 referral that day only, free B12.
- Escalating despite bankruptcy: free-test offer extended through year-end, referral value doubled on event days, B12 sweetener added, rebrand rolling throughout. No core TRT price cuts found.
Ad and social evidence
Low T Center runs geo-targeted Google CPC (indexed landing URLs with Google UTM parameters). No dated SynergenX Instagram or Facebook offer posts surfaced in search.
UNVERIFIED: current clinic count (64 is from July; closures during bankruptcy unknown). The $82.3M debt figure (secondary source only). Whether July “$250 for 250” credits were actually paid in November. What the headline “as low as $59/mo” includes: the $105/mo self-inject figure is what September verification supports, so $59 is not a comparable price. August 2026 offers. Meta Ad Library contents (HTTP 403, Nov 12, 2026).
Sources: synergenxhealth.com/patient-resources/special-offers/, /free-testosterone-test/, /full-hormone-test/, /greenwood-grand-opening/ (checked Nov 12, 2026) · BusinessWire Jul 3, Jul 14, Sep 24, Nov 3, 2026 · cases.stretto.com, Case No. 26-90644 · lowtcenter.com (checked Nov 12, 2026).
Franchise · In-personDirection: steady, no national shift
Footprint: 38–42 clinics (the company says both “38+” and “42”); 13 states claimed. Kentucky/Tennessee core, expanding into Florida, Ohio, Indiana, Illinois. ~50,000 patients claimed. The Villages, FL opened around August 2026. Founded 2016, franchising since Sept 2020.
Current offers · Nov 2026
Labs + consult $129–$169, per clinic
No national pricing published. Hormone membership $159–$219/mo (medications, labs, and recovery services included, 3-month commitment). November promos are local only: Bowling Green veterans $99 labs plus a free t-shirt; women joining get a recovery guest pass; first recovery session free.
Offer history, ad evidence, sources
Aug–Nov 2026
- Most aggressive moment was September: $99 labs (Columbus, IN all month; London, KY $50 off).
- October–November reverted to audience-specific promos (first responders $75 off, veterans) and community events.
- No new service lines, guarantees, or rebrand in the window.
Ad and social evidence
One Meta campaign confirmed indirectly: Optimize U Destin's aesthetics offer page carries Facebook campaign UTMs from agency “Staplerz.”
UNVERIFIED: exact clinic count (38 vs 42) and full state list (the sitemap only rendered KY/TN). Meta Ad Library contents (HTTP 403, Nov 12, 2026).
Sources: optimizeucenters.com (checked Nov 12, 2026) · wellnessfranchisehq.com/guides/optimize-u-franchise-cost · lakeandsumterstyle.com, The Villages opening (Aug 2026).
Franchise · Anti-aging & wellnessDirection: promotional rotation
Footprint: 75 units across 22 states (Franchise Herald, Nov 5, 2026). Closed 2025 at 68 locations and $55M system sales, up 27.8%. Average 2025 gross revenue $1,020,756 across 49 franchised centers open 12+ months (median $862,165); top location $3.54M (2026 FDD figures via franchise reporting).
Current offers · Nov 2026
HRT from $50/week + $200 credit
From $50/week on a live paid-ad landing page (read Nov 12, 2026), free consultation, labs billed separately. $200 credit toward a wellness membership or peptide package (minimum 3-month commitment), valid through Dec 31, 2026. No national weight-loss price; the St. Louis location publishes semaglutide $375/mo and tirzepatide $490/mo. November is holiday cadence: Pre-Holiday Sale Nov 3, Black Friday member early access Nov 9–26, Botox Day Nov 18.
Offer history, ad evidence, sources
Aug–Nov 2026
- Aug–Sep: summer IV and filler bundles, ending Sep 30.
- October: membership acquisition plus the first-ever peptide and wellness credit in the headline promo. Peptides entered the headline offer in October.
- November: holiday member-early-access cadence. No base price reductions found.
Ad and social evidence
Paid-ad landing pages live at ads.get4everyoung.com (read Nov 12, 2026).
UNVERIFIED: national weight-loss and peptide pricing (not published at brand level). The TRT intro of $99/mo for the first 3 months plus a $149 intro lab panel was last seen September 2026 and is UNVERIFIED for November. Meta Ad Library contents (HTTP 403, Nov 12, 2026).
Sources: ads.get4everyoung.com/whitpain-hrt-50-female (read Nov 12, 2026) · 4everyoungstl.com/treatments/weight-loss · wellnessfranchisehq.com (published Nov 7, 2026) · Franchise Herald, Nov 5, 2026 · sharpsheets.io franchise cost analysis.
Telehealth · Public (NYSE: HIMS)Direction: aggressive category expansion
Scale: Q3 2026 revenue $890.4M, up 49% year over year; 2.788M subscribers (up 13% YoY but down 100,000 sequentially); $105/mo revenue per subscriber; net loss $33M; gross margin compressed to 57% from 74% (reported Nov 9, 2026). FY2026 guidance tightened to $3.13–$3.15B. Testosterone is not available in all 50 states and no public state list exists.
Current offers · Nov 2026
Injectable TRT live since Oct 21
Compounded twice-weekly subcutaneous injection, generic testosterone cypionate weekly IM, and FDA-approved oral Kyzatrex. On hims.com/testosterone (read Nov 12, 2026): $49 membership fee at checkout, treatment from $49/mo, 2 labs per year included, no insurance, no FSA/HSA. Weight loss is brand-name only: Wegovy Pill from $149/mo, Zepbound $299, Foundayo $149, plus a mandatory $149/mo membership ($39 first month), so all-in is roughly $298–$600/mo. Peptides+ launches late November (sermorelin, glutathione, NAD+, B12), no prices disclosed.
Offer history, ad evidence, sources
Aug–Nov 2026
- Jul 29: FTC, Utah, and LA County sued over subscription and cancellation practices. Five more states joined Nov 10–11.
- Oct 21: injectable + oral TRT launch, billed as its largest men's-health launch to date.
- Nov 2: “The Tune Up” event with Calvin Johnson. Nov 6: Lilly deal signed (Zepbound and Foundayo at Lilly self-pay prices). Nov 9: Q3 results plus Peptides+ announcement.
- US weight-loss marketing was deliberately moderated in Q3, with a marketing ramp planned for Q1 2027. The theme is mass testing as the funnel, not price offers.
- Live overhang: DEA telemedicine flexibilities for controlled substances expire Dec 31, 2026. That expiry directly affects the TRT rollout.
Ad and social evidence
A third-party Aug 25 to Sep 2 sweep found 19 Meta ads, eligibility and “Why Hims?” angles.
UNVERIFIED: injectable and oral TRT tier prices ($79/$159/$179 per month are single-sourced to one Oct 23 review site). Enclomiphene current price ($99/mo prepay through Oct 17 vs $49/mo on Oct 23: repricing or different variant, unresolved). Peptides+ pricing. Testosterone state list. Compounded semaglutide at $199/mo is still cited by competitor sites but absent from Hims' brand-only catalog: likely stale. Scope of the expanded FTC suit could not be reconciled across reports. Meta Ad Library contents (HTTP 403, Nov 12, 2026).
Sources: investors.hims.com releases, Oct 21 and Nov 9, 2026 · hims.com/testosterone and hims.com/weight-loss (read Nov 12, 2026) · Lilly deal reporting (Nov 2026).
Telehealth · LongevityDirection: flat prices, heavier discounting
Scale: claims 300,000+ patients tested and 65,000+ treated (March 2026 investor memo). Not available in 14 states + DC; partial availability in 7 more. Why top 10: top-rated telehealth TRT across third-party rankings, and the heaviest Meta advertiser in this set.
Current offers · verified live Nov 12, 2026
Premium TRT $45 first month, then $155/mo
First month struck through from $155 on Hone's own buy page. Includes a 50+ biomarker test at Quest, physician video consult, quarterly retesting. Medications billed separately (testosterone injections from $28/mo), so realistic all-in is roughly $183–$215+/mo. Basic $25/mo; Plus $135/mo. Weight loss: no semaglutide or tirzepatide at all, only compounded liraglutide at $160/mo.
Offer history, ad evidence, sources
Aug–Nov 2026
- Headline prices flat all four months. Two real moves: sermorelin raised $130 to $175/mo in September (+35%), and the steep $45 first-month discount appearing by November, the first intro-price promo seen in the window (launch date unknown).
- Sep 22: BODYBAR Pilates partnership: 20% off testing plus a free Premium year one for ~21,000 members, 40+ studios.
- Expansion, not price: Lp(a) heart testing added; perimenopause push in October. Women's hormone creative now outpaces testosterone creative.
Ad and social evidence
507 ads in Meta Ad Library, all running (Sprites proxy read, Oct 5, 2026): 86% image, 14% video, and 108 new ads launched in one week in early October. First-time national TV advertiser in H1 2026, $2.11M spend.
UNVERIFIED: the $45 first-month offer's launch date (live Nov 12, absent from all Aug–Oct reviews). Revenue and headcount conflict across sources. Plus tier status still “in transition.” Meta ad spend (only an unverified agency estimate exists). Direct Meta Ad Library read was not possible; Hone is covered via the Sprites proxy only.
Sources: buy.honehealth.com/mens-opt/membership/ (read Nov 12, 2026) · honehealth.com/mens/testosterone-replacement-therapy/ · sprites.ai/hone-health-ads (Oct 5, 2026) · menshealthatlas.com (Hone ranked #3, injectable TRT).
Telehealth · Performance medicineDirection: most aggressive repricing
Scale: Financial Times #7 on the Americas' Fastest Growing Companies 2026. $20M raised total. Claims profitability and 8-figure ARR, doubling year over year. No patient count published. TRT in 47 of 51 jurisdictions. Open FDA warning letter, Jun 8, 2026 (MARCS-CMS 730095), over compounded GLP-1 claims; no closeout posted as of Nov 12, 2026.
Current offers · verified Nov 11, 2026
Headline $99.99/mo, on prepay only
The $99.99 headline holds only on 9-month (enclomiphene) / 10-month (injectable) prepaid plans: $899.91 / $999.90 upfront, cannot be ended early. Month-to-month: $179.99 (enclomiphene/cream), $199.99 (injectable), $249.99 (oral T). Medications included; labs extra ($99.99 starter kit). King Protocol roughly $199.99/mo with a money-back guarantee if testosterone does not increase. GLP-1: brand-name orforglipron $199.99/mo; tirzepatide $99.99/mo on a 12-month plan. No compounded semaglutide (dropped October).
Offer history, ad evidence, sources
Aug–Nov 2026
- October GLP-1 overhaul: dropped compounded semaglutide entirely, dropped month-to-month GLP-1, cut tirzepatide roughly 50–58% (12-month $240.66 to $99.99/mo), added brand-name orforglipron at $199.99/mo.
- November TRT restructure: 12-month plan became 9-month; 6-month injectable became 10-month; month-to-month enclomiphene cut $199.99 to $179.99; 3-month cut $149.99 to $119.99/mo.
- Pattern: cheaper sticker prices funded by longer lock-ins, plus a post-FDA-letter pivot from compounded semaglutide to tirzepatide and brand-name orals.
Ad and social evidence
Paid Meta and Reddit run in-house (a Director of Paid Media plus an open specialist role). No dated organic Instagram or Facebook posts found for Aug–Nov; that is a gap, not evidence of absence.
UNVERIFIED: patient count (not published anywhere found). November first-month promos: the October $49.99 limited-time offer and “50% off first month” may not survive the Nov 11 restructure. GLP-1 state list. Maximus's own site lists brand-name tirzepatide at both $449.99 and $1,249.99/mo (unresolved). No Ad Library counts retrievable; direct read was not possible.
Sources: maximustribe.com (direct read Nov 11, 2026) · GlobeNewswire, Apr 3, 2026 (FT ranking) · FDA warning letter MARCS-CMS 730095 (Jun 8, 2026) · medswitcher.com (Maximus ranked #1) · menshealthatlas.com/providers/maximus/.
Telehealth · Premium, diagnostics-ledDirection: flat prices, creator-led
Scale: claims all 50 states for the program; third parties say 45–47. Diagnostics explicitly unavailable in NY, NJ, RI, HI. Why top 10: premium segment leader and the price ceiling of this market.
Current offers · verified Nov 12, 2026
$749 before any medication
$299 one-time Guided Optimization intake + $450 minimum lab panel. Ongoing treatment “averages $80–$200/month.” No subscription. Medication prices are not published anywhere; TRT, peptide, and GLP-1 monthly costs are third-party estimates only ($225–$275/mo for TRT). Diagnostics: Total Health Panel Comprehensive (80+ biomarkers) $495; range $150–$1,950. No free labs, consult, or first-month offer. Only standing 10% creator codes.
Offer history, ad evidence, sources
Aug–Nov 2026
- None on price. The $299 + $450 structure was identical at every dated checkpoint from Aug 19 through Nov 12.
- Only escalation was promotional: late-October “Win Your Year” sweepstakes (2 x $3,500 credit, entries closed Nov 8) pushed by large fitness creators, plus a Black Friday / Cyber Monday paid-social campaign for Diagnostics, confirmed via UTM parameters only.
Ad and social evidence
Appears in Sprites.ai's Oct 5, 2026 Ad Library read with a longest-running ad of 301 days.
UNVERIFIED: medication prices (unpublished by design). Patient counts, revenue, growth (nothing public). HQ and founding year conflict across sources. Black Friday Diagnostics offer details (campaign confirmed via UTMs only). “Win Your Year” winners (no announcement found by Nov 12). Meta Ad Library contents (HTTP 403, Nov 12, 2026).
Sources: marekhealth.com/faq (read Nov 12, 2026) · marekdiagnostics.com lab bundles and Total Health Panel Comprehensive · sprites.ai/healthcare-ads (Oct 5, 2026) · menshealthatlas.com (Marek ranked #4, injectable TRT).
Telehealth · BudgetDirection: flat base, sharper funnel
Scale: roughly 44–45 states (exact count conflicts across sources: 44 vs 45 vs 47). Marketing is SEO, blog content, and review volume: 4.9 stars, 2,075 Google reviews shown on-site. No patient count, revenue, or growth figures public. Why top 10: the price floor of telehealth TRT, and the sharpest November top-of-funnel move in the window.
Current offers · verified Nov 12, 2026
TRT $99.99/mo + $69 starter labs
TRT $99.99/mo (2.5-month minimum, roughly $250 first charge). TRT + HCG $180/mo. Enclomiphene $99.99/mo. Labs $129, but the November $69 TRT Starter Plan cuts the full lab panel to $69 for new patients only. Includes medications, supplies, shipping, unlimited consults. No membership, no contract, no refunds. Weight loss: tirzepatide only, $219/mo any dose, compounded with B12 (page updated Oct 27, 2026).
Offer history, ad evidence, sources
Aug–Nov 2026
- Base prices never moved all window. TRT held at $99.99/mo throughout.
- September: weekend sale START25, 25% off first order ($75/mo TRT), expired Sep 7, on their own page.
- October: a first-month promo existed (confirmed Oct 12); its value was not recorded. Gap.
- November: $69 TRT Starter Plan launch. Promotional intensity stepped up twice while the base price stayed flat.
Ad and social evidence
Not in Sprites' 83-brand Ad Library list, which is not proof it runs no ads. No dated TRT Nation Instagram or Facebook offer post found for Aug–Nov; a live check of its social pages would fill this.
UNVERIFIED: current peptide and ED prices (only April 2026 figures exist; stale). October first-month promo value. Whether $219 tirzepatide requires a 3-month plan. A claimed 12% military discount is contradicted by another source. Exact state count. Aggregator codes (20% codes, “$50 off storewide”) are user-reported, not company offers. Meta Ad Library contents (HTTP 403, Nov 12, 2026).
Sources: trtnation.com/testosterone-replacement-therapy/, /new-patient-lab-orders/, /weekend-sale-is-live/, GLP-1 page updated Oct 27, 2026 (all read Nov 12, 2026) · menshealthatlas.com/providers/trt-nation/ · NY Post online TRT roundup, Oct 2026.
Telehealth · TRT-ledDirection: flat prices, reputation repair
Scale: claims “over 400,000 patients served” (verified live Nov 12, 2026; already present in August). Self-reported only, no independent verification found. Based in Vero Beach, FL. TRT state exclusions narrowed from 12 states (July/August) to AL/ID only by Sep 21, 2026, or the 12-state list was GLP-1-specific all along; unresolved.
Current offers · verified live Nov 12, 2026
TRT from $79/mo, 12-month prepay
Tiers from the main TRT page: $79/mo on 12-month prepay ($948 upfront), $109/mo on 6-month, $139/mo month-to-month. Labs extra ($95 panel; $340 first year), so first-year all-in is roughly $1,288. Free virtual consultation. 20%-off price-match guarantee live on-page. Weight loss: semaglutide $270/mo flat or $149/mo prepaid; tirzepatide $249/mo billed quarterly (still $249 on Nov 11). Peptides: sermorelin $585 per 3 months, NAD+ $369 per 8–10 weeks. Homepage now leads with longevity and biomarker testing (133+ biomarkers, biological age).
Offer history, ad evidence, sources
Aug–Nov 2026
- Price ladder flat after September. August shows conflicting readings ($119/mo on Aug 6 vs $139 tiers Aug 26–31) across PeterMD's own pages and funnels: likely funnel inconsistency, not provably a repricing. PeterMD's own pages still disagree with each other on price, labs, and states.
- Aug 10, 2026: BBB rating went from F to A+ accredited, a reputational reset.
- Trustpilot removed PeterMD's profile (13,900+ reviews) for guideline violations, yet the site still displays “4.9/5, based on 20k+ reviews” today.
Ad and social evidence
Known Meta advertiser in general terms (its CGO bio cites paid-media campaigns), but no specific current creative could be verified. No verified official Instagram or Facebook handles, follower counts, or dated social posts found for Aug–Nov 2026.
UNVERIFIED: the 400K patient figure (self-reported). Founding year (sources conflict: 2014 vs 2016 vs 2019 vs 2021). Month-to-month semaglutide rate, ED/hair/bundle pricing, veterans offer (last checked Jul–Sep). Enclomiphene price conflicts across sources. Meta Ad Library contents (HTTP 403, Nov 12, 2026).
Sources: getpetermd.com/, /begin-trt/, /about-us/ (read Nov 12, 2026) · AccessNewswire PeterMD pricing explainer · glp1newstoday.com PeterMD review · NY Post online TRT roundup (“Best Quick Online TRT Clinic”).
No competitor matches that filter and search. Clear the search or pick another model.